These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 7927364)
1. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma. Amiral J; Adam M; Mimilla F; Larrivaz I; Chambrette B; Boffa MC Hybridoma; 1994 Jun; 13(3):205-13. PubMed ID: 7927364 [TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of monoclonal antibodies to thrombomodulin. Tsuneyoshi N; Fukudome K; Higuchi K; Kimoto M Hybridoma (Larchmt); 2005 Aug; 24(4):189-96. PubMed ID: 16120024 [TBL] [Abstract][Full Text] [Related]
3. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Ishii H; Nakano M; Tsubouchi J; Ishikawa T; Uchiyama H; Hiraishi S; Tahara C; Miyajima Y; Kazama M Thromb Haemost; 1990 Apr; 63(2):157-62. PubMed ID: 2163551 [TBL] [Abstract][Full Text] [Related]
4. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma. Ohlin AK; Larsson K; Hansson M J Thromb Haemost; 2005 May; 3(5):976-82. PubMed ID: 15869594 [TBL] [Abstract][Full Text] [Related]
5. Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay. Nakamura M; Ohta H; Kume N; Hayashida K; Tanaka M; Mitsuoka H; Kaneshige T; Misaki S; Imagawa K; Shimosako K; Ogawa N; Kita T; Kominami G J Pharm Biomed Anal; 2010 Jan; 51(1):158-63. PubMed ID: 19632802 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies directed against the epidermal growth factor-like domains of thrombomodulin inhibit protein C activation in vitro. Oosting JD; Preissner KT; Derksen RH; de Groot PG Br J Haematol; 1993 Dec; 85(4):761-8. PubMed ID: 7522520 [TBL] [Abstract][Full Text] [Related]
7. Elevation of soluble thrombomodulin antigen levels in the serum and urine of streptozotocin-induced diabetes model rats. Nakano M; Furutani M; Shinno H; Ikeda T; Oida K; Ishii H Thromb Res; 2000 Jul; 99(1):83-91. PubMed ID: 10904105 [TBL] [Abstract][Full Text] [Related]
8. Thrombomodulin: an overview and potential implications in vascular disorders. Boffa MC; Karmochkine M Lupus; 1998; 7 Suppl 2():S120-5. PubMed ID: 9814688 [TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin--endothelial thrombin receptor in blood of patients with unstable angina pectoris. Wiśniewska E; Wodyńska T; Kulwas A; Kotschy M; Nartowicz E; Paczuski R; Michalski A Med Sci Monit; 2001; 7(2):256-9. PubMed ID: 11257732 [TBL] [Abstract][Full Text] [Related]
10. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF. Bellucci S; Ignatova E; Jaillet N; Boffa MC Thromb Haemost; 1993 Nov; 70(5):736-42. PubMed ID: 8128427 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal anti-cardiolipin antibodies from New Zealand Black x New Zealand White F1 mice react to thrombomodulin. Haruta K; Kobayashi S; Hirose S; Horiai A; Ohyanagi M; Tanaka M; Kawano T; Shirai T; Takasaki Y; Hashimoto H J Immunol; 1998 Jan; 160(1):253-8. PubMed ID: 9551978 [TBL] [Abstract][Full Text] [Related]
12. Thrombomodulin levels in the plasma and joint fluid from patients with rheumatoid arthritis. Ichikawa Y; Takaya M; Shimizu H; Moriuchi J; Uchiyama M; Morita K; Hoshina Y; Horiki T Tokai J Exp Clin Med; 1993 Dec; 18(3-6):123-6. PubMed ID: 7701524 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of an enzyme immunoassay for plasma thrombomodulin]. Amano K; Kaku M; Inaba H; Ueda M; Fukutake K; Arai M; Yorifuji H; Fujimaki M Rinsho Byori; 1991 Sep; 39(9):967-71. PubMed ID: 1658417 [TBL] [Abstract][Full Text] [Related]
14. One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. Kodama S; Uchijima E; Nagai M; Mikawatani K; Hayashi T; Suzuki K Clin Chim Acta; 1990 Dec; 192(3):191-9. PubMed ID: 1962742 [TBL] [Abstract][Full Text] [Related]
15. Plasma thrombomodulin as a marker of endothelium damage. Boffa MC; Karochkine M; Bérard M Nouv Rev Fr Hematol (1978); 1991; 33(6):529-30. PubMed ID: 1667951 [TBL] [Abstract][Full Text] [Related]
16. Mouse monoclonal anti-human thrombomodulin antibodies bind to and activate endothelial cells through NF-kappaB activation in vitro. Nara H; Okamoto H; Minota S; Yoshio T Arthritis Rheum; 2006 May; 54(5):1629-37. PubMed ID: 16646025 [TBL] [Abstract][Full Text] [Related]
17. Recombinant thrombomodulin of different domains for pharmaceutical, biomedical, and cell transplantation applications. Wang L; Jiang R; Sun XL Med Res Rev; 2014 May; 34(3):479-502. PubMed ID: 23804235 [TBL] [Abstract][Full Text] [Related]
18. Anti-thrombomodulin antibodies and venous thrombosis. Guermazi S; Mellouli F; Trabelsi S; Bejaoui M; Dellagi K Blood Coagul Fibrinolysis; 2004 Oct; 15(7):553-8. PubMed ID: 15389121 [TBL] [Abstract][Full Text] [Related]
19. Plasma thrombomodulin in health and diseases. Takano S; Kimura S; Ohdama S; Aoki N Blood; 1990 Nov; 76(10):2024-9. PubMed ID: 2173634 [TBL] [Abstract][Full Text] [Related]
20. [Soluble thrombomodulin: as a marker of endothelial injury]. Maruyama I; Shinmyozu K Rinsho Byori; 1994 Jun; 42(6):563-8. PubMed ID: 8051797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]